565 related articles for article (PubMed ID: 26262501)
1. Deleterious Impact of Donor-Specific Anti-HLA Antibodies Toward HLA-Cw and HLA-DP in Kidney Transplantation.
Bachelet T; Martinez C; Del Bello A; Couzi L; Kejji S; Guidicelli G; Lepreux S; Visentin J; Congy-Jolivet N; Rostaing L; Taupin JL; Kamar N; Merville P
Transplantation; 2016 Jan; 100(1):159-66. PubMed ID: 26262501
[TBL] [Abstract][Full Text] [Related]
2. Clinical significance of low pre-transplant donor specific antibodies (DSA) in living donor kidney recipients with negative complement-dependent cytotoxicity crossmatches (CDCXM), and negative flow cytometry crossmatches (FLXM) - A single-center experience.
Olszowska-Zaremba N; Gozdowska J; Zagożdżon R
Transpl Immunol; 2022 Oct; 74():101672. PubMed ID: 35868613
[TBL] [Abstract][Full Text] [Related]
3. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
[TBL] [Abstract][Full Text] [Related]
4. Pretransplant anti-HLA-Cw and anti-HLA-DP antibodies in sensitized patients.
Ling M; Marfo K; Masiakos P; Aljanabi A; Lindower J; Glicklich D; de Boccardo G; Greenstein S; Chapochnick-Friedmann J; Kayler L; Kinkhabwala M; Akalin E
Hum Immunol; 2012 Sep; 73(9):879-83. PubMed ID: 22841893
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and impact of HLA and MICA allele mismatching on donor-specific antibodies induction in kidney transplant rejection.
Romphruk AV; Simtong P; Suntornnipat J; Sudwilai Y; Cheunta S; Chan-On C; Leelayuwat C
Nephrology (Carlton); 2021 Oct; 26(10):833-841. PubMed ID: 34197005
[TBL] [Abstract][Full Text] [Related]
6. Impact of Preformed Donor-Specific Anti-HLA-Cw and Anti-HLA-DP Antibodies on Acute Antibody-Mediated Rejection in Kidney Transplantation.
Laboux T; Lenain R; Visentin J; Flahaut G; Chamley P; Provôt F; Top I; Kerleau C; Labalette M; Choukroun G; Couzi L; Blancho G; Hazzan M; Maanaoui M
Transpl Int; 2023; 36():11416. PubMed ID: 38076227
[TBL] [Abstract][Full Text] [Related]
7. Preformed complement-activating low-level donor-specific antibody predicts early antibody-mediated rejection in renal allografts.
Lawrence C; Willicombe M; Brookes PA; Santos-Nunez E; Bajaj R; Cook T; Roufosse C; Taube D; Warrens AN
Transplantation; 2013 Jan; 95(2):341-6. PubMed ID: 23197178
[TBL] [Abstract][Full Text] [Related]
8. Donor-specific HLA-DQ antibodies may contribute to poor graft outcome after renal transplantation.
DeVos JM; Gaber AO; Knight RJ; Land GA; Suki WN; Gaber LW; Patel SJ
Kidney Int; 2012 Sep; 82(5):598-604. PubMed ID: 22622504
[TBL] [Abstract][Full Text] [Related]
9. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
[TBL] [Abstract][Full Text] [Related]
10. Pretransplant immunologic risk assessment of kidney transplant recipients with donor-specific anti-human leukocyte antigen antibodies.
Marfo K; Ajaimy M; Colovai A; Kayler L; Greenstein S; Lubetzky M; Gupta A; Kamal L; de Boccardo G; Masiakos P; Kinkhabwala M; Akalin E
Transplantation; 2014 Nov; 98(10):1082-8. PubMed ID: 24873780
[TBL] [Abstract][Full Text] [Related]
11. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
Lee PC; Ozawa M
Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
[TBL] [Abstract][Full Text] [Related]
12. Impact of preformed and de novo anti-HLA DP antibodies in renal allograft survival.
Redondo-Pachón D; Pascual J; Pérez-Sáez MJ; García C; Hernández JJ; Gimeno J; Mir M; Crespo M
Transpl Immunol; 2016 Feb; 34():1-7. PubMed ID: 26603314
[TBL] [Abstract][Full Text] [Related]
13. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
[TBL] [Abstract][Full Text] [Related]
14. Analysis of preformed donor-specific anti-HLA antibodies characteristics for prediction of antibody-mediated rejection in kidney transplantation.
Malheiro J; Tafulo S; Dias L; Martins LS; Fonseca I; Beirão I; Castro-Henriques A; Cabrita A
Transpl Immunol; 2015 Mar; 32(2):66-71. PubMed ID: 25661873
[TBL] [Abstract][Full Text] [Related]
15. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
[TBL] [Abstract][Full Text] [Related]
16. Donor-specific HLA antibodies: risk factors and outcomes after kidney transplantation.
Kanter Berga J; Pallardo Mateu LM; Beltran Catalan S; Puig Alcaraz N; Sancho Calabuig A; Gavela Martinez E; Avila Bernabeu A; Crespo Albiach J
Transplant Proc; 2011; 43(6):2154-6. PubMed ID: 21839219
[TBL] [Abstract][Full Text] [Related]
17. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.
Schinstock CA; Gandhi M; Cheungpasitporn W; Mitema D; Prieto M; Dean P; Cornell L; Cosio F; Stegall M
Transplantation; 2017 Oct; 101(10):2429-2439. PubMed ID: 28009780
[TBL] [Abstract][Full Text] [Related]
18. Incidence and impact of anti-HLA-DP antibodies in renal transplantation.
Hörmann M; Dieplinger G; Rebellato LM; Briley KP; Bolin P; Morgan C; Haisch CE; Everly MJ
Clin Transplant; 2016 Sep; 30(9):1108-14. PubMed ID: 27327607
[TBL] [Abstract][Full Text] [Related]
19. De novo donor specific antibodies and patient outcomes in renal transplantation.
DeVos JM; Patel SJ; Burns KM; Dilioglou S; Gaber LW; Knight RJ; Gaber AO; Land GA
Clin Transpl; 2011; ():351-8. PubMed ID: 22755430
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Luminex-based Algorithms to Define Unacceptable HLA Antibodies in CDC-crossmatch Negative Kidney Transplant Recipients.
Zecher D; Bach C; Preiss A; Staudner C; Utpatel K; Evert M; Jung B; Bergler T; Böger CA; Spriewald BM; Banas B
Transplantation; 2018 Jun; 102(6):969-977. PubMed ID: 29470350
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
